869 related articles for article (PubMed ID: 23383557)
1. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
2. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
3. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
Phillips M; Gleeson K; Hughes JM; Greenberg J; Cataneo RN; Baker L; McVay WP
Lancet; 1999 Jun; 353(9168):1930-3. PubMed ID: 10371572
[TBL] [Abstract][Full Text] [Related]
4. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
5. Volatile biomarkers of pulmonary tuberculosis in the breath.
Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
[TBL] [Abstract][Full Text] [Related]
6. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
7. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
8. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
9. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
10. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC/MS) analysis: A prospective cohort study.
Zhang Y; Guo L; Qiu Z; Lv Y; Chen G; Li E
J Clin Lab Anal; 2020 Dec; 34(12):e23526. PubMed ID: 33150682
[TBL] [Abstract][Full Text] [Related]
12. Detection of volatile biomarkers of therapeutic radiation in breath.
Phillips M; Byrnes R; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mehta V; Mundada M; Patel U; Ramakrishna N; Schiff PB; Zhang X
J Breath Res; 2013 Sep; 7(3):036002. PubMed ID: 23793046
[TBL] [Abstract][Full Text] [Related]
13. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
14. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
15. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.
Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H
Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705
[TBL] [Abstract][Full Text] [Related]
16. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
[TBL] [Abstract][Full Text] [Related]
17. Geographical variation in the exhaled volatile organic compounds.
Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
[TBL] [Abstract][Full Text] [Related]
18. A rapid method for breath analysis in cystic fibrosis patients.
Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
[TBL] [Abstract][Full Text] [Related]
19. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
20. Optimization of volatile organic compounds sampling from dairy cow exhaled breath using polymer-based solid-phase extraction cartridges for gas chromatographic analysis.
Eichinger J; Reiche AM; Dohme-Meier F; Fuchsmann P
J Breath Res; 2024 Apr; 18(3):. PubMed ID: 38547532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
